Innovations in Pharmaceutical Technology (IPT)
IPT provides a platform for cutting-edge ideas, concepts, and developments shaping the future of pharmaceutical R&D.
Install App?
Innovations in Pharmaceutical Technology (IPT)
www.iptonline.com
This is how the Install App dialog will look like once your App goes live.
New Programme Expands Access to PacBio’s Highly Accurate Sequencing Systems by Providing Flexible Financing
14 September 2023 -- California, US -- PacBio, a leading developer of high-quality, highly accurate sequencing solutions, announced PacBio Capital, a programme that offers customers the ability to lease PacBio sequencing systems – Revio, Onso and Sequel IIe – easily and cost-effectively.
"Through PacBio Capital, we can expand our ability to reach customers and new markets," said Christian Henry, president and chief executive officer of PacBio. "By making it possible to lease our game-changing sequencing systems, customers can conserve capital and keep monthly payments down while continuing with their groundbreaking research."
PacBio Capital allows qualified customers to choose capital and operating lease structures with highly competitive rates and a six-month same as cash financing option. The streamlined credit and funding process can enable labs to fast-track their purchase of PacBio systems and allow more customers to benefit from the sub-$1,000 HiFi human genome on the recently released Revio system.
"It’s a win/win for PacBio and our current and future customers," said Jeff Eidel, chief commercial officer at PacBio. "With PacBio Capital, we aim to get more systems into the hands of customers faster by offering them the flexibility to lease our products under the terms that work best for them."
Visit: www.pacb.com
About PacBio
PacBio is a premier life science technology company that is designing, developing and manufacturing advanced sequencing solutions to help scientists and clinical researchers resolve genetically complex problems. Our products and technologies stem from two highly differentiated core technologies focused on accuracy, quality and completeness which include our HiFi long-read sequencing and our SBB short-read sequencing technologies. Our products address solutions across a broad set of research applications including human germline sequencing, plant and animal sciences, infectious disease and microbiology, oncology and other emerging applications.
![[object Object]](https://cdn.magloft.com/pwa-665/article/image/c8cfb798-e19d-4bbe-b36c-3e8cfe75ef4e.png?optimizer=image&width=360&aspect_ratio=3:4)
Broken String Biosciences Strengthens Senior Leadership Team to Accelerate Product Development
2 October 2023 -- Cambridge, UK -- Broken String Biosciences, a genomics company building a technology platform to drive the development of cell and gene therapies that are safer by design, announced the expansion of its senior leadership team with the appointments of Vincent Smith, PhD, as chief technology officer and Jessica Rich as VP Business Development
![[object Object]](https://cdn.magloft.com/pwa-665/article/image/b2fdfcd9-5174-45b6-8d1d-9b641ad7095a.png?optimizer=image&width=360&aspect_ratio=3:4)
Austrian State Secretary to speak at FlyPharma Europe 2023
29 September 2023 -- London, UK -- FlyPharma Europe will welcome Mr Florian Tursky, the Austrian state secretary, to the conference on 10 October, where he will deliver an opening speech. He will join a host of expert industry speakers from both pharma and cargo sectors
![[object Object]](https://cdn.magloft.com/pwa-665/article/image/e27828aa-7431-445b-8b52-d6d3b9228649.png?optimizer=image&width=360&aspect_ratio=3:4)
Revvity Expands Access to Base Editing Technology with Aim to Accelerate Discovery to Cure
26 September 2023 -- Massachusetts, US -- Revvity unveils its groundbreaking Pin-point base editing platform reagents, providing researchers with unparalleled access to implement the advanced gene editing technique in their preclinical laboratories
![[object Object]](https://cdn.magloft.com/pwa-665/article/image/589e2bd7-77cb-43d6-ac4a-f0180b72bb89.png?optimizer=image&width=360&aspect_ratio=3:4)
Cellectricon Expands Neuroscience Contract Research Portfolio with New Neuroplasticity Services
26 September 2023 -- Molndal, Sweden -- Cellectricon, a services provider dedicated to advancing neuroscience drug discovery, announced the launch of a new service module for neuroplasticity research
![[object Object]](https://cdn.magloft.com/pwa-665/article/image/3d896106-9683-4d84-b2bf-6db473ad2a53.png?optimizer=image&width=360&aspect_ratio=3:4)
Start Codon Invites Life Sciences Leaders, Founders and Investors to Innovation Showcase 2023
26 September 2023 -- Cambridge, UK -- Start Codon, a life science and healthcare venture-building fund, is pleased to invite life sciences leaders, entrepreneurs and investors from across the life science and biotech industries to attend their Innovation Showcase 2023
1
Human-Centred Design: From Inception to Integration
IPT sat down with Dr Chris Vincent at PDD, to understand more about the digital innovations that are leading design and whether technologies like Extended Reality (XR) can be beneficial to the process
2
The Importance of Temperature Control in Pharmaceutical Analysis
As technology within the analysis sphere continues to evolve, temperature control is becoming increasingly important for drug discovery and research
3
Providing Support Throughout the Patient Journey
Concierge services are critical to helping patients navigate technology and other logistics in a decentralised clinical trial. How best can they be implemented?
